117 related articles for article (PubMed ID: 1923996)
1. [Immunophenotypic characteristics of the epithelial cells of ovarian neoplasms].
Harłozińska-Szmyrka A
Postepy Hig Med Dosw; 1991; 45(1-2):45-62. PubMed ID: 1923996
[TBL] [Abstract][Full Text] [Related]
2. [New prospects in the combined use of tumor markers in epithelial neoplasms of the ovary].
Indraccolo SR; Cecchi A; Thodos A; Brandi S; Carta G
Ann Ostet Ginecol Med Perinat; 1991; 112(1):36-40. PubMed ID: 1929097
[TBL] [Abstract][Full Text] [Related]
3. Mouse monoclonal antibodies to human epithelial differentiation antigens expressed on the surface of ovarian carcinoma ascites cells.
Mattes MJ; Look K; Furukawa K; Pierce VK; Old LJ; Lewis JL; Lloyd KO
Cancer Res; 1987 Dec; 47(24 Pt 1):6741-50. PubMed ID: 3677104
[TBL] [Abstract][Full Text] [Related]
4. [Tumor markers in epithelial carcinoma of the ovary].
Cottini M; Carnino F; Iskra L; Rapisarda V; Mossetti C
Minerva Ginecol; 1986 Jun; 38(6):479-84. PubMed ID: 3461313
[No Abstract] [Full Text] [Related]
5. Marker profile of mesothelial cells versus ovarian carcinoma cells.
van Niekerk CC; Jap PH; Thomas CM; Smeets DF; Ramaekers FC; Poels LG
Int J Cancer; 1989 Jun; 43(6):1065-71. PubMed ID: 2659540
[TBL] [Abstract][Full Text] [Related]
6. Adjunct to the diagnostic distinction between adenocarcinomas of the ovary and the colon utilizing a monoclonal antibody (COL-4) with restricted carcinoembryonic antigen reactivity.
Thor A; Muraro R; Gorstein F; Ohuchi N; Viglione M; Szpak CA; Johnston WW; Schlom J
Cancer Res; 1987 Jan; 47(2):505-12. PubMed ID: 2431771
[TBL] [Abstract][Full Text] [Related]
7. CA 125 as a marker in epithelial ovarian cancer: Alone and in comparison with CEA.
Bhatavdekar JM; Shah NG; Trivedi SN; Karelia NH; Balar DB; Patel TB
Indian J Cancer; 1987 Dec; 24(4):222-31. PubMed ID: 3505511
[No Abstract] [Full Text] [Related]
8. A comparative study of mucin-like carcinoma-associated antigen (MCA), CA 125, CA 19-9 and CEA in patients with ovarian cancer.
Koelbl H; Schieder K; Neunteufel W; Bieglmayer C
Neoplasma; 1989; 36(4):473-8. PubMed ID: 2770933
[TBL] [Abstract][Full Text] [Related]
9. [Possibilities and limitations of the clinical use of specific monoclonal antibodies for epithelial ovarian carcinomas: CA125K].
Pozzi V; D'Onofrio T; Cappa F; Mascaretti G; Meggiorini ML; Nusiner MP; Danese M
Minerva Ginecol; 1985 May; 37(5):253-7. PubMed ID: 3861960
[No Abstract] [Full Text] [Related]
10. Identification of a meiotically expressed carbohydrate antigen in ovarian carcinoma: I. Immunohistochemical localization.
Skinner SM; Lee VH; Kieback DG; Jones LA; Kaplan AL; Dunbar BS
Anticancer Res; 1997; 17(2A):901-6. PubMed ID: 9137425
[TBL] [Abstract][Full Text] [Related]
11. Immunological reactivity of mucinous and serous ovarian adenocarcinomas.
Harłozińska-Szmyrka A; Slesak B; Richter R; Rabczyński J; Cisło M
Cancer Detect Prev; 1986; 9(3-4):347-58. PubMed ID: 3017557
[TBL] [Abstract][Full Text] [Related]
12. Expression of monoclonal antibody-defined tumor markers in four carcinomas.
Wu JT
Ann Clin Lab Sci; 1989; 19(1):17-26. PubMed ID: 2916833
[TBL] [Abstract][Full Text] [Related]
13. Antigens associated with epithelial ovarian carcinomas.
Bast RC
Prog Clin Biol Res; 1989; 288():73-83. PubMed ID: 2785696
[No Abstract] [Full Text] [Related]
14. Tumor-associated glycoprotein (TAG-72) in ovarian carcinomas defined by monoclonal antibody B72.3.
Thor A; Gorstein F; Ohuchi N; Szpak CA; Johnston WW; Schlom J
J Natl Cancer Inst; 1986 Jun; 76(6):995-1006. PubMed ID: 3520078
[TBL] [Abstract][Full Text] [Related]
15. [The dosage of CA 125 in carcinoma of the ovary and other solid neoplasms].
Scheinberg MA; Baracat F; Nunes AP; Murakami S
Rev Paul Med; 1988; 106(3):145-6. PubMed ID: 2471993
[No Abstract] [Full Text] [Related]
16. Characterization of the antigen (CAK1) recognized by monoclonal antibody K1 present on ovarian cancers and normal mesothelium.
Chang K; Pai LH; Batra JK; Pastan I; Willingham MC
Cancer Res; 1992 Jan; 52(1):181-6. PubMed ID: 1727378
[TBL] [Abstract][Full Text] [Related]
17. [CA 125 (cancer antigen 125), a new tumor associated antigen recognized by monoclonal antibody].
Suzuki H; Teshima K; Noda K
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2719-23. PubMed ID: 6594978
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibody against human ovarian tumor-associated antigens.
Poels LG; Peters D; van Megen Y; Vooijs GP; Verheyen RN; Willemen A; van Niekerk CC; Jap PH; Mungyer G; Kenemans P
J Natl Cancer Inst; 1986 May; 76(5):781-91. PubMed ID: 3517452
[TBL] [Abstract][Full Text] [Related]
19. [Tumor markers: new prospects in the diagnosis and clinical monitoring of malignant epithelial neoplasms of the ovary].
Gadducci A; Ferdeghini M; Prato B; Bartolini T; Nicolini A; Scatena P; Facchini V; Bianchi R; Fioretti P
Ann Ostet Ginecol Med Perinat; 1985; 106(1):34-9. PubMed ID: 2994537
[No Abstract] [Full Text] [Related]
20. Tumor markers in the human ovary and its neoplasms. A comparative immunohistochemical study.
Nouwen EJ; Hendrix PG; Dauwe S; Eerdekens MW; De Broe ME
Am J Pathol; 1987 Feb; 126(2):230-42. PubMed ID: 3548400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]